Related content

Follow-up of nondetectable prostate carcinoma (pT0) after prolonged PSA-monitored neoadjuvant hormonal therapy followed by radical prostatectomy

By Kollermann J.   Caprano J.   Budde A.   Weidenfeld H.   Weidenfeld M.   Hopfenmuller W.   Helpap B.  

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 476-480

Elsevier

Access to resources Recommend Favorite

Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose - analysis of tumor response and prognosis

By Valicenti R.K.   Gomella L.G.   Ismail M.   Mulholland S.G.   Strup S.   Petersen R.O.   Corn B.W.   Lu J.D.  

Urology, Vol. 52, Iss. 6, 1998-12 ,pp. : 1034-1040

Elsevier

Access to resources Recommend Favorite

pT0 after Radical Prostatectomy: Overtreatment for Insignificant Prostate Cancer?

By Hammerer P.  

European Urology, Vol. 45, Iss. 1, 2004-01 ,pp. : 35-35

Elsevier

Access to resources Recommend Favorite

Pathological T0 Prostate Cancer without Neoadjuvant Therapy: Clinical Presentation and Follow-Up

By Herkommer K.   Kuefer R.   Gschwend J.E.   Hautmann R.E.   Volkmer B.G.  

European Urology, Vol. 45, Iss. 1, 2004-01 ,pp. : 36-41

Elsevier

Access to resources Recommend Favorite

Long-term follow-up after triple treatment of prostate cancer stage pT3

By Schelin Sonny   Madsen Mikael   Palmqvist Elisabeth   Makela Erik   Klintenberg Claes   Aus Gunnar  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 3, 2009-04 ,pp. : 186-191

Informa Healthcare

Access to resources Recommend Favorite